Biomaterial Surface Nanotopography Induced IgG Unfolding Modulates Macrophage Innate Immune Responses
Source abstract
Abstract
Implantable devices often encounter challenges related to adverse immune reactions and rejection due to poor host responses. Biomaterial surface nanotopography is known to modulate the host immune responses at cellular and molecular levels. In this study, we investigate how nanoscale modifications of surface topography influence the adsorption of Immunoglobulin G, the resultant attachment of innate immune cells, and inflammatory responses. We engineered model surfaces with well-defined nanoscale features of 16, 38, and 68 nm and ensured uniform surface chemistry. We demonstrated that nanoscale dimensions significantly impact IgG adsorption, leading to conformational changes. IgG adsorption and unfolding promoted macrophage attachment, migration, and activation. Although IgG adsorption led to an increase in both pro- and anti-inflammatory markers, surfaces with preadsorbed IgG promoted a net anti-inflammatory response, favoring the M2 macrophage phenotype, demonstrating the importance of surface topography in modulating IgG adsorption and conformational changes in shaping the behavior of immune cells. These findings pave the way for designing implantable medical devices that enable targeted modulation of immune responses, leading to improved patient outcomes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Cell Adhesion Molecules Research · Advanced Biosensing Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Experimental Therapeutics Laboratory, UniSA Clinical and Health Sciences
University of South Australia
College of Medicine and Public Health
Flinders University
UniSA STEM
Infrared Microspectroscopy Beamline, Australian Synchrotron, 800 Blackburn Road, Clayton, Victoria 3168, Australia
Funding
National Health and Medical Research Council · Australian Research Council · Flinders Foundation
References (69)
Show source-provided references
1. 10.1109/TNB.2004.82427610.1109/TNB.2004.824276 ↗
2. 10.1016/j.msec.2018.05.07510.1016/j.msec.2018.05.075 ↗
3. 10.1016/j.bioactmat.2021.11.02410.1016/j.bioactmat.2021.11.024 ↗
4. 10.3389/fbioe.2020.0016610.3389/fbioe.2020.00166 ↗
5. 10.1002/adfm.20150087510.1002/adfm.201500875 ↗
6. 10.3390/bioengineering1001004310.3390/bioengineering10010043 ↗
7. 10.1002/adfm.20180745310.1002/adfm.201807453 ↗
8. 10.1016/j.apsusc.2022.15351810.1016/j.apsusc.2022.153518 ↗
9. 10.1038/ncomms539410.1038/ncomms5394 ↗
10. 10.1016/j.jim.2007.04.00110.1016/j.jim.2007.04.001 ↗
11. 10.1016/j.it.2019.01.00510.1016/j.it.2019.01.005 ↗
12. 10.1038/nri.2017.10610.1038/nri.2017.106 ↗
13. 10.1002/btpr.258610.1002/btpr.2586 ↗
14. 10.1021/acs.langmuir.1c0271010.1021/acs.langmuir.1c02710 ↗
15. 10.1002/jbm.a.3647210.1002/jbm.a.36472 ↗
16. 10.1016/j.apsusc.2024.15964410.1016/j.apsusc.2024.159644 ↗
17. 10.1021/acsami.4c1288310.1021/acsami.4c12883 ↗
18. 10.1021/acsbiomaterials.4c0110310.1021/acsbiomaterials.4c01103 ↗
19. 10.1016/j.actbio.2019.02.04810.1016/j.actbio.2019.02.048 ↗
20. 10.1002/jbm.a.3410410.1002/jbm.a.34104 ↗
21. 10.1016/j.actbio.2013.10.03510.1016/j.actbio.2013.10.035 ↗
22. 10.1002/jbm.a.3186310.1002/jbm.a.31863 ↗
23. 10.1016/j.mtadv.2021.10018710.1016/j.mtadv.2021.100187 ↗
24. 10.1002/adfm.20180745310.1002/adfm.201807453 ↗
25. 10.3390/nano101003110.3390/nano1010031 ↗
26. 10.1021/am201320a10.1021/am201320a ↗
27. 10.1021/jp111221g10.1021/jp111221g ↗
28. 10.1021/acsanm.8b0045810.1021/acsanm.8b00458 ↗
29. 10.1093/nar/gky49710.1093/nar/gky497 ↗
30. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
31. 10.1021/la901947510.1021/la9019475 ↗
32. 10.1039/C5NR08329J10.1039/C5NR08329J ↗
33. 10.1039/c2sm25221j10.1039/c2sm25221j ↗
34. 10.1039/C5CC00260E10.1039/C5CC00260E ↗
35. 10.3390/nano1204068210.3390/nano12040682 ↗
36. 10.1039/C5CC00260E10.1039/C5CC00260E ↗
37. 10.1021/acs.chemmater.7b0302310.1021/acs.chemmater.7b03023 ↗
38. 10.1111/j.1365-2249.2009.04081.x10.1111/j.1365-2249.2009.04081.x ↗
39. 10.1016/S0065-2776(08)60486-110.1016/S0065-2776(08)60486-1 ↗
40. 10.1038/nri220610.1038/nri2206 ↗
41. 10.1021/la062192310.1021/la0621923 ↗
42. 10.1016/j.pep.2009.12.01410.1016/j.pep.2009.12.014 ↗
43. Layng S. C. · Journal of Undergraduate Chemistry Research · 2021 · 20 · 43
44. 10.1016/j.matpr.2023.04.20010.1016/j.matpr.2023.04.200 ↗
45. 10.1177/03913988990220010810.1177/039139889902200108 ↗
46. 10.1039/C8AN01543K10.1039/C8AN01543K ↗
47. 10.1021/acs.analchem.2c0143110.1021/acs.analchem.2c01431 ↗
48. 10.1007/978-1-0716-2930-7_1510.1007/978-1-0716-2930-7_15 ↗
49. 10.1002/jor.2043010.1002/jor.20430 ↗
50. 10.1155/2007/6903610.1155/2007/69036 ↗
51. 10.1002/jlb.49.6.55610.1002/jlb.49.6.556 ↗
52. 10.1182/blood.V74.3.1058.105810.1182/blood.V74.3.1058.1058 ↗
53. 10.1021/acs.langmuir.0c0209410.1021/acs.langmuir.0c02094 ↗
54. 10.1111/imcb.1223610.1111/imcb.12236 ↗
55. 10.1038/s41598-017-08121-810.1038/s41598-017-08121-8 ↗
56. 10.1016/j.freeradbiomed.2023.03.02510.1016/j.freeradbiomed.2023.03.025 ↗
57. 10.1186/1556-276X-7-39410.1186/1556-276X-7-394 ↗
58. 10.1016/j.pharmthera.2015.06.01010.1016/j.pharmthera.2015.06.010 ↗
59. 10.1002/adhm.20150084510.1002/adhm.201500845 ↗
60. 10.1002/smsc.20230008010.1002/smsc.202300080 ↗
61. 10.3389/fimmu.2014.0025310.3389/fimmu.2014.00253 ↗
62. 10.1021/acs.langmuir.4c0164210.1021/acs.langmuir.4c01642 ↗
63. 10.1038/s41598-024-62484-310.1038/s41598-024-62484-3 ↗
64. 10.1038/boneres.2017.5910.1038/boneres.2017.59 ↗
65. 10.1016/j.biomaterials.2020.12001410.1016/j.biomaterials.2020.120014 ↗
66. 10.1186/s12951-022-01721-110.1186/s12951-022-01721-1 ↗
67. 10.2147/IJN.S18843910.2147/IJN.S188439 ↗
68. 10.3390/ijms2307355810.3390/ijms23073558 ↗
69. 10.1016/j.tice.2023.10211210.1016/j.tice.2023.102112 ↗